Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£ |
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Item 5.02. |
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
Item 9.01. |
Financial
Statements and Exhibits.
|
Exhibit
Number
|
Description |
99.1 |
Press
Release dated September 21, 2007.
|
Keryx Biopharmaceuticals, Inc. | ||
(Registrant) | ||
|
|
|
Date: September 24, 2007 | By: | /s/ Beth F. Levine |
Beth F. Levine |
||
Chief
Compliance Officer, General Counsel and
Secretary
|
Exhibit
Number
|
Description |
99.1 |
Press
Release dated September 21,
2007.
|